Nutritional Supplementation in Cognitive Aging
To evaluate the effect of supplemented fruit juice on memory function in older adults
Status: Recruiting (N/A). Started on June 1st, 2006.
Enrollment: 60 subjects
Study Type: Interventional
Study Design:
- Allocation: Randomized
- Endpoint Classification: Efficacy Study
- Intervention Model: Parallel Assignment
- Masking: Double Blind (Subject
- Investigator
- Outcomes Assessor)
- Primary Purpose: Prevention
Conditions:
Interventions:
- Dietary Supplement: purple grape juice (Welch's Concord Grape Juice)
- Dietary Supplement: placebo juice
Eligibility
Inclusion Criteria:
- Mild Cognitive Impairment
Exclusion Criteria:
Weight of under 100 or over 210 pounds
Chronic use of pain medication
- Gender
Both
- Mininum Age
66 Years
- Maximum Age
N/A
- Healthy Volunteers
No
Resources
Source: University of Cincinnati
Authority: United States: Institutional Review Board
Locations
-
University of Cincinnati
Cincinnati
Ohio
45267-0559
United States
Officials
Robert Krikorian, Ph.D. (Principal Investigator, University of Cincinnati)
Sponsors
University of Cincinnati (Lead Sponsor)
Welch Foods Incorporated (Collaborator)
References
None.
Links
None.
- Date Verified
- March 1st, 2011
- First Received
- March 3rd, 2011
- Last Changed
- March 3rd, 2011
Information obtained from ClinicalTrials.gov on June 09, 2011. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.